Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join


Nov 09, 2020 10:00 AM - Nov 10, 2020 3:45 PM

(US Eastern Standard Time)

Real World Evidence Conference

Session 5: What Will the Generation and Application of RWE Look Like in 2030?

Session Chair(s)

Dorothee  Bartels, PhD, MSc

Dorothee Bartels, PhD, MSc

Chief Digital Officer

Aetion, Germany

Steven A. Anderson, PhD

Steven A. Anderson, PhD

Director, Office of Biostatistics and Epidemiology, CBER

FDA, United States

This session will explore what the successful generation and application of RWD and RWE might look like in 2030. It is expected that development of key elements such as robust data, validated methods and knowledge, as well as engagement of a broad range of interdisciplinary experts including data scientists, epidemiologists, statisticians, clinical scientists will be critical to acceptance of RWE in supporting claims of therapeutic effectiveness. Success may further include surmounting challenges such as integration of high-quality data from a variety of sources, development of new and innovative methods, bridging accross multiple disciplines and stakeholders and others. Panel members will discuss these and other critical elements necessary for the successful generation and application of real world evidence in 2030.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Describe two key elements necessary to the success of RWE application
  • Identify the experts needed to advance generation and use of RWE
  • Identify challenges to the potential successful application of RWE


Jon D. Duke, MD, MS


Jon D. Duke, MD, MS

Georgia Tech Research Institute, United States

Director of Health Informatics

Richard  Forshee, PhD


Richard Forshee, PhD

FDA, United States

Deputy Director, OBPV CBER

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.